Clinical trial
Personalized Ex Vivo Drug Screening and Genomics Profiling to Guide Individualized Treatments for Children With Relapsed or Refractory Solid Tumors and Leukemias
NCT03860376 is registered in ClinicalTrials.gov with Florida International University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Ex Vivo Drug Screening and Genomics Profiling to Guide Individualized Treatments for Children With Relapsed or Refractory Solid Tumors and Leukemias
- Lead sponsor
- Florida International University
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 21, 2019
- Completion date
- December 31, 2022
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia, recurrent childhood brain tumor, recurrent childhood brainstem glioma, recurrent childhood ependymoma, recurrent childhood gliosarcoma, recurrent childhood large cell lymphoma, recurrent childhood lymphoblastic lymphoma, recurrent childhood rhabdomyosarcoma, recurrent childhood soft tissue sarcoma, refractory childhood acute lymphoblastic leukemia, refractory childhood hodgkin lymphoma, refractory childhood malignant germ cell neoplasm, refractory chronic myelogenous leukemia, bcr-abl1 positive